Global Value & Access Lead, Rare Haematology (PNH/HSCT-TMA)

Alexion; Barcelona; Hybrid; EUR 150,000 - 190,000; Full time

Job summary

Alexion, AstraZeneca Rare Disease, seeks a Director to shape global value, access and pricing strategies for Haematology indications, with a focus on PNH and HSCT-TMA. You will lead cross-functional efforts, influence lifecycle management, and drive payer strategies across markets.

The role requires deep expertise in HTA, payer environments, and evidence development, with responsibility for global Dossier updates and country readiness in collaboration with HEOR, Medical and Commercial teams.

Qualifications

• Demonstrated leadership in rare diseases market access, pricing and reimbursement.
• Experience shaping global value propositions for hematology indications.
• Ability to translate clinical and economic evidence into payer value stories.

Responsibilities

• Lead global market access and pricing strategies for Haematology indications.
• Collaborate with country access reps and GMMA to support PNH/LCM lifecycle management.
• Develop evidence-generation plans and P&R materials for priority markets.

Skills

Strategic Leadership

HTA expertise

Payer negotiations

Cross-functional leadership

Education

PhD/PharmD/biomedical sciences or economics

Job description

Alexion, AstraZeneca Rare Disease, seeks a Director to shape global value, access and pricing strategies for Haematology indications, with a focus on PNH and HSCT-TMA. You will lead cross-functional efforts, influence lifecycle management, and drive payer strategies across markets.

The role requires deep expertise in HTA, payer environments, and evidence development, with responsibility for global Dossier updates and country readiness in collaboration with HEOR, Medical and Commercial teams.